Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 51 - Drug-Induced Movement Disorders

  • from Section 4: - Dyscoordinative and Otherwise Inappropriate Motor Behaviors
  • Edited by Erik Ch. Wolters, Universität Zürich, Christian R. Baumann, Universität Zürich
  • Book:
    International Compendium of Movement Disorders
    Published online:
    07 January 2025
    Print publication:
    06 February 2025, pp 642-650

  • Summary

    This chapter provides an overview of legal drug-induced (neuroleptic and non-neuroleptic) movement disorders. Awareness of medications causing involuntary movements is critical to determine the appropriate treatment strategy. Certain movement disorders that are not typically associated with a central nervous system lesion (e.g., akathisia, tics, etc.) often do not require extensive testing beyond obtaining a thorough history and a neurologic exam, but other abnormal movements (e.g., ataxia, myoclonus, etc.) that are often caused by structural lesions may require neuroimaging for exclusion of an alternate etiology. In this chapter, we include all commonly used legal (marketed) drugs that have been implicated to induce movement disorders; nevertheless, due to the countless case reports, as well as the growing, endless list of such medications, our survey undoubtedly falls short on some compounds. The illegal parkinsonism-inducing drugs (street drugs) are discussed in Chapter 35.